Highlights Medicamen Biotech Limited

Equities

MEDICAMEQ

INE646B01010

Market Closed - Bombay S.E. Other stock markets 03:30:51 31/05/2024 pm IST			5-day change	1st Jan Change
500.6 ^INR	+4.18%		-3.45%	-16.90%

31/05	Medicamen Biotech Receives Observations from Greek Regulatory Body; Shares Up 4%	MT
29/05	Medicamen Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Medicamen Biotech Receives Observations from Greek Regulatory Body; Shares Up 4%	31/05	MT
Medicamen Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	29/05	CI
Medicamen Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02	CI
Medicamen Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	10/11	CI
Medicamen Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	08/23/08	CI
Medicamen Biotech Limited Recommends Final Dividend for Financial Year 2022-23	29/23/29	CI
Medicamen Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29/23/29	CI
Medicamen Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	10/23/10	CI
Medicamen Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	11/22/11	CI
Medicamen Biotech Forays into Domestic Indian Pharmaceutical Business	04/22/04	MT
Medicamen Biotech Forms New Unit	26/22/26	MT
Medicamen Biotech Ties Up with Danish Pharmaceutical Firm for Manufacturing of Drugs	12/22/12	MT
Medicamen Biotech Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	10/22/10	CI
Medicamen Biotech : Disclosure under SEBI Takeover Regulations	18/22/18	PU
Medicamen Biotech Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	25/22/25	CI
Medicamen Biotech Limited Recommends Final Dividend for the Financial Year 2021-22	25/22/25	CI
Medicamen Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	08/22/08	CI
Promoter Group Narrows Stake in Medicamen Biotech	04/22/04	MT
Promoter Group Lowers Stake in Medicamen Biotech to 2.93%	10/21/10	MT
Medicamen Biotech's Consolidated Net Profit Climbs in Fiscal Q2	05/21/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Medicamen Biotech Limited

Equities

MEDICAMEQ

INE646B01010

Highlights

Filters